Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Pfizer Ltd. Regulatory Filings 2024

Jan 9, 2024

60507_rns_2024-01-09_0a886fed-9085-4118-a09d-618ee312a0fb.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

January 9, 2024

The Corporate Relationship Dept. BSE Limited 1st Floor, P.J.Towers Dalal Street, Fort Mumbai – 400 001 Scrip Code: 500680

The Manager, Listing Dept. The National Stock Exchange of India Ltd. Exchange Plaza, 5th Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 051 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Pfizer Limited - Results of the Postal Ballot (e-voting).

Ref: Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

This is further to our letter dated December 7, 2023 enclosing Postal Ballot Notice along with explanatory statement ("Notice") dated October 28, 2023 issued to the Members of the Company, seeking their approval for appointment of Mr. P. Rengan (DIN: 10362899) as a Whole-time Director of the Company designated as Executive Director – Plant Operations for a period of 5 years with effect from October 28, 2023 through Ordinary Resolution.

In accordance with the provisions of Section 110 of the Companies Act, 2013 read with the rules made thereunder and various circulars issued by Ministry of Corporate Affairs, the Company conducted postal ballot by providing remote e-voting facility to the Members. The e-voting period as specified in the Notice ended on Saturday, January 6, 2024 at 5:00 p.m (IST).

Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, enclosed herewith please find the results of e-voting on the aforesaid resolution in the prescribed format along with Scrutinizer's Report issued by Mr. Nrupang Dholakia, Scrutinizer.

Based on the Scrutinizer's Report, we are pleased to inform you that the resolution contained in the Notice has been duly passed by the Members. The copy of the said Results is also available on the Company's website at www.pfizerltd.co.in

We Request you to please take the above on record.

Thanking you,

Yours truly, For Pfizer Limited

Digitally signed by PRAJEET NAIR Date: 2024.01.09 16:05:27 +05'30'

Prajeet Nair Director – Corporate Services & Company Secretary

CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerltd.co.in

Co
Na
mp
an
y
me		 P
F
I
Z
E
R
L
I
M
I
T
E
D
/
f
he
Da
A
G
M
E
G
M
te
t
o
l n
be
f s
ha
ho
l
de
d
da
To
ta
te
um
r o
re
rs
on
re
co
r		 1
1
8
7
7
4
f s
ha
ho
l
de
in
he
ing
i
he
in
No
t
t
t
t
. o
re
rs
p
res
en
m
ee
e
r
p
ers
on
or
d
Pro
Pro
Gr
ter
ter
mo
s a
n
mo
ou
p
:		 0
b
l
ic:
Pu		 0
f
ha
ho
l
de
de
d
he
ing
hro
h
i
de
No
S
V
t
ten
t
t
t
. o
re
rs
a
m
ee
ug
o
d
Pro
Pro
Gr
ter
ter
mo
s a
n
mo
ou
p
:		 0
b
l
ic:
Pu		 0
/
lu
d:
(
d
l
)
Re
ion
ire
Or
ina
Sp
ia
t
so
re
q
u
ry
ec		 (
)
O
R
D
I
N
A
R
Y -
A
P
P
O
I
N
T
M
E
N
T
O
F
M
R.
P.
R
E
N
G
A
N
D
I
N:
1
0
3
6
2
8
9
9
A
S
A
W
H
O
L
E-
T
I
M
E
D
I
R
E
C
T
O
R
O
F
T
H
E
C
O
M
P
A
N
Y
F
O
R
A
P
E
R
I
O
D
O
F
5
Y
E
A
R
S
W
I
T
H
E
F
F
E
C
T
F
R
O
M
O
C
T
O
B
E
R
2
8,
2
0
2
3.
/
he
he
W
t
ter
ter
r p
rom
o
p
rom
o
g
rou
p
are
/
d
he
da
lu
?
in
in
ion
ter
te
t
t
es
ag
en
res
o		 No
Ca
teg
ory		 f
de
ing
Mo
Vo
t
o		 f s
ha
No
. o
res
(
)
he
l
d
1		 f v
No
tes
. o
o
(
)
l
le
d
2
p
o		 f
%
l
le
d
Vo
Po
tes
o
d
ing
ts
tan
on
ou
ha
s
res
(
)
=[
(
)
/
(
)
]
*
3
2
1
1
0
0		 f
in
No
Vo
tes
. o
–
fav
(
)
4
ou
r		 f
No
Vo
tes
. o
–
(
)
ins
5
t
ag
a		 f
%
in
Vo
tes
o
fav
tes
ou
r o
n v
o
l
le
d
p
o
(
)
=[
(
)
/
(
)
]
*1
6
2
0
0
4		 f
%
Vo
tes
o
ins
t o
tes
ag
a
n v
o
l
le
d
p
o
(
)
=[
(
)
/
(
)
]
*1
2
0
0
7
5
d
Pro
Pro
Gr
ter
ter
mo
an
mo
ou
p		 E-
Vo
ing
t		 2
9
2
4
3
0
4
2		 2
9
2
4
3
0
4
2		 1
0
0.
0
0
0
0		 2
9
2
4
3
0
4
2		 0 1
0
0.
0
0
0
0		 0.
0
0
0
0
l
l
Po		 2
9
2
4
3
0
4
2		 0 0.
0
0
0
0		 0
0		 0 0.
0
0
0
0		 0.
0
0
0
0
l
l
lo
Po
Ba
ta
t
s
(
)
f a
l
b
le
i
ica
p
p		 2
9
2
4
3
0
4
2		 0 0.
0
0
0
0		 0
0		 0 0.
0
0
0
0		 0.
0
0
0
0
E-
Vo
ing
t		 8
2
7
2
5
9
8		 7
6
2
7
9
8
6		 9
2.
2
0
7
9		 7
3
0
2
1
5
8		 3
2
5
8
2
8		 9
5.
7
2
8
5		 4.
2
7
1
4
b
l
ic-
i
ion
Pu
Ins		 l
l
Po		 8
2
7
2
5
9
8		 0 0.
0
0
0
0		 0
0		 0 0.
0
0
0
0		 0.
0
0
0
0
t
tu
t
s		 l
l
lo
Po
Ba
ta
t
s
(
)
i
f a
l
ica
b
le
p
p		 8
2
7
2
5
9
8		 0 0.
0
0
0
0		 0
0		 0 0.
0
0
0
0		 0.
0
0
0
0
b
l
ic-
i
ion
Pu
No
Ins
t
tu
t
n
s		 ing
E-
Vo
t		 8
2
3
2
0
9
2		 3
6
9
2
9		 0.
4
4
8
6		 3
5
9
9
6		 9
3
3		 9
7.
4
7
3
5		 2.
5
2
6
4
l
l
Po		 8
2
3
2
0
9
2		 0 0.
0
0
0
0		 0
0		 0 0.
0
0
0
0		 0.
0
0
0
0
l
l
lo
Po
Ba
ta
t
s
(
f a
)
i
l
ica
b
le
p
p		 8
2
3
2
0
9
2		 0 0.
0
0
0
0		 0
0		 0 0.
0
0
0
0		 0.
0
0
0
0
l
To
ta		 3
2
4
5
7
4
7
7		 3
6
9
0
9
7
5
7		 8
0.
6
7
7
1		 3
6
8
9
6
5
1
1		 3
2
6
6
7
1		 9
9.
1
1
4
7		 0.
8
8
3
5

Digitally signed by PRAJEET NAIR Date: 2024.01.09

16:05:55 +05'30'

SCRUTINIZER'S REPORT

To, Mr. Pradip Shah The Chairman Pfizer Limited

SUB: REPORT ON THE POSTAL BALLOT PROCESS FOR THE RESOLUTION AS SET OUT IN THE NOTICE OF POSTAL BALLOT DATED OCTOBER 28, 2023

Dear Sir,

    1. Dholakia & Associates LLP, Company Secretaries ("firm11 ) were appointed as the scrutinizer by Pfizer Limited ("Company11 ) by the Board of Directors of the Company to scrutinize the postal ballot voting process (voting by e-voting/remote e-voting) in connection with the subject matter.
    1. I, CS Nrupang B. Dholakia, Designated Partner of the firm, submit my report as under:
  • 2.1 The Company completed the despatch of Notice of postal ballot on Thursday, December 7, 2023, through electronic mode to the Members whose names appeared in the register of members or in the register of beneficial owners maintained by the Depositories as at the close of business hours on Friday, December 1, 2023 ('cut-off date') and whose e-mail IDs were registered with Company/Registrar and Transfer Agent of the Company/ Depositories, pursuant to the applicable General Circulars issued by the Ministry of Corporate Affairs for conduct of postal ballot.
  • 2.2 The postal ballot was conducted only through remote e-voting system which was provided by KFin Technologies Limited ("KFinTech11 ) pursuant to the above referred circulars, hence, postal ballot forms were not required to be sent by the Company.
  • 2.3 The remote e-voting period commenced on Friday, December 8, 2023 (9:00 a.m. 1ST) and ended on Saturday, January 6, 2024. (5:00 p.m. 1ST)
  • 2.4 I have received a complete record of votes cast bye-voting mode on Monday, January 8, 2024 from KFin Technologies Limited, the 'e-voting Agency'. The voting period concluded on Saturday, January 6, 2024 (5:00 p.m. 1ST).
  • 2.5 Particulars of all the votes cast by electronic mode have been entered in a register separately maintained for the purpose in electronic mode.
  • 2.6 I am obligated under Section 110 of the Companies Act, 2013 and the Rules framed thereunder to retain the postal ballot related data till the time the Company signs the minutes or proceedings. Once the copy of minutes or proceedings is provided, the same will be handed over to the Company.

  • 2.7 The votes cast by corporate/institutional Members who have e-mailed the scanned certified true copy of the board resolution/authority letter, etc. at email ID: [email protected] or have uploaded on the website of KFinTech i.e. www.evoting.kfintech.com have been considered valid.
    1. The Members who have abstained from voting in the e-voting have been treated as invalid (details attached in Annexure - II)
    1. In accordance with the basis of rejection (as per Annexure I) and on proper scrutiny of all the postal ballot votes cast by way of e-voting, I report the result of the postal ballot as under:

Resolution No. 1 - Appointment of Mr. P. Rengan (DIN: 10362899) as a Whole-time Director of the Company for a period of 5 years with effect from October 28, 2023

(a) Details of voting, as received from thee-voting agency is as follows:

Particulars Number
of
Members
who
cast vote		 No. of Equity Shares of
the Nominal Value of
Rs. 10/-
each (Votes
cast)
Total Votes received 597 3,69,08,138
Less: Total Number of Invalid Votes 6 181
Total Number of Valid Votes 591 3,69,07,957

(b) Details of Voting:

Particulars Aggregate of voting No. of Equity Shares
of the Nominal Value
10/-
of
each
Rs.
(votes cast)		 %
of
valid
votes
received
Total valid votes
received		 591 3,69,07,957 100
Assented to
Resolution		 548 3,65,81,196 99.11
Dissented to
Resolution		 43 3,26,761 0.89

    1. You may accordingly declare the result of the postal ballot voting process.
    1. All the relevant records of voting by e-voting/remote e-voting will be e-mailed to Mr. Prajeet Nair, Director - Corporate Services & Company Secretary of the Company after the Chairman considers, approves and signs the minutes of the postal ballot.

CS Nrupang B. Dholakia Designated Partner Dholakia & Associates LLP (Company Secretaries) FCS: 10032 CP No: 12884

UDIN:F010032E003152138 Place: Mumbai Date: January 9, 2024

"ANNEXURE-I"

BASIS OF REJECTION

    1. Institutional Member (other than Individuals, HUF, NRI, etc.) has not uploaded scanned copy/ hard copy of the relevant Board Resolution / Authority Letter/ Power of Attorney, etc. or e-mailed at [email protected] or have not uploaded on the website of KFinTech i.e. www .evoting. kfintech .com
    1. Board Resolution/ Authority Letter/ Power of Attorney, etc. does not grant power in favour of the person who has exercised voting right.

"ANNEXURE-11"

REPORT FOR INVALID VOTES

Resolution No. 1 - Appointment of Mr. P. Rengan (DIN: 10362899) as a Whole-time Director of the Company for a period of 5 years with effect from October 28, 2023

Sr.
No.		 Category No. of Votes Total number of Invalid
votes (equity share of the
nominal value of INR 10/-
each)
VOTING THROUGH ELECTRONIC MODE
1. Board Resolution / Power of Attorney not
uploaded/ sent		 NIL NIL
2. Abstained from voting 6 181
TOTAL 6 181

CS Nrupang B. Dholakia Designated Partner Dholakia & Associates LLP (Company Secretaries) FCS: 10032 CP No: 12884

UDIN: F010032E003152138 Place: Mumbai Date: January 9, 2024

More from Pfizer Ltd.

Regulatory Filings 2026
May 19
Regulatory Filings 2026
May 12
Regulatory Filings 2026
May 12
Regulatory Filings 2026
May 12
Regulatory Filings 2026
May 12
Notice of Dividend Amount 2026
May 12
Notice of Dividend Amount 2026
May 12
Notice of Dividend Amount 2026
May 12
Regulatory Filings 2026
May 12
Interim / Quarterly Report 2026
May 12
View all filings →